Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Eric Pelfrene"'
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 10, Iss 1, Pp 1-6 (2021)
Abstract Background Antimicrobial resistance (AMR) is a growing global problem to which the ongoing COVID-19 pandemic may further contribute. With resources deployed away from antimicrobial stewardship, evidence of substantial pre-emptive antibiotic
Externí odkaz:
https://doaj.org/article/709310eb95ba45b28990bb2748580b48
Autor:
Eric Pelfrene, Martin Harvey Allchurch, Nsengi Ntamabyaliro, Victoria Nambasa, Fátima V Ventura, Nithyanandan Nagercoil, Marco Cavaleri
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 13, Iss 6, p e0007381 (2019)
Externí odkaz:
https://doaj.org/article/4a409dedf06d4d26bf50406ef792ac3b
Publikováno v:
Viruses, Vol 11, Iss 9, p 771 (2019)
With most interest we read the contribution made by Fauconnier on phage therapy regulation [...]
Externí odkaz:
https://doaj.org/article/557c702b8d1d44f580a0a302df6587cf
Publikováno v:
Clinical Microbiology and Infection
Background The paucity of licensed monoclonal antibodies (mAbs) in the infectious diseases arena strongly contrasts with the ready availability of these therapeutics for use in other conditions. Aims This narrative review aims to assess the potential
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c12286ab0d45af9b9a56bfc3b6d099e
https://doi.org/10.1016/j.cmi.2018.04.024
https://doi.org/10.1016/j.cmi.2018.04.024
Publikováno v:
Bacteriophages ISBN: 9783319405988
Bacteriophages
Bacteriophages
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ea16619593cdc050f830235d134687f
https://doi.org/10.1007/978-3-319-41986-2_51
https://doi.org/10.1007/978-3-319-41986-2_51
Publikováno v:
Phage Therapy: A Practical Approach ISBN: 9783030267353
With the recognition of the threat posed by bacterial multi-drug resistance, the bacteriophage treatment concept has been revived as an alternative in the armamentarium. Over the last decade, research efforts on bacteriophage therapy have intensified
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cecc59a54dc68523d81b5ceb99f5a2be
https://doi.org/10.1007/978-3-030-26736-0_14
https://doi.org/10.1007/978-3-030-26736-0_14
Autor:
Eric Pelfrene, Jonathan Cohen, Derek C. Angus, Flávia Ribeiro Machado, Neill K. J. Adhikari, Thierry Calandra, Steven M. Opal, Kevin J. Tracey, Katia Jaton, Tom van der Poll, Julie Delaloye, Jean Louis Vincent, Stefano Giulieri
Publikováno v:
Lancet infectious diseases, 15(5), 581-614. Lancet Publishing Group
Sepsis is a common and lethal syndrome: although outcomes have improved, mortality remains high. No specific anti-sepsis treatments exist; as such, management of patients relies mainly on early recognition allowing correct therapeutic measures to be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::204730adb23df6a2e5f59f5595dd774f
https://doi.org/10.1016/s1473-3099(15)70112-x
https://doi.org/10.1016/s1473-3099(15)70112-x
Autor:
Marco Cavaleri, Victoria Nambasa, Fátima V. Ventura, Nsengi Ntamabyaliro, Martin Harvey Allchurch, Nithyanandan Nagercoil, Eric Pelfrene
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 13, Iss 6, p e0007381 (2019)
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::390477ae20aba4f4a481ca6cc61de9e4
https://doi.org/10.1371/journal.pntd.0007381
https://doi.org/10.1371/journal.pntd.0007381
Autor:
Benjamin Lorenz, Sabrina Comic-Savic, Helen K. Donnelly, Kunal Merchant, Charles Knirsch, Richard G. Wunderink, Barry Eisenstein, Demissie Alemayehu, Christina Reith, Eric Pelfrene, Rosemary Tiernan, Pamela Tenaerts, Radu Botgros, Jonas Santiago
BACKGROUND Resistant bacteria are one of the leading causes of hospital-acquired/ventilator-associated bacterial pneumonia (HABP/VABP). HABP/VABP trials are complex and difficult to conduct due to the large number of medical procedures, adverse event
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b88a53df0ef66e4c898501d7e0efafec
https://doi.org/10.1093/cid/ciw316
https://doi.org/10.1093/cid/ciw316
Autor:
Demissie Alemayehu, Gary J. Noel, Pamela Tenearts, Christina Reith, Rosemary Tiernan, Charles Knirsch, Sabrina Comic-Savic, Eric Pelfrene, Jonas Santiago, Vance G. Fowler, Jennifer C. Goldsack, Kunal Merchant, David Friedland, Radu Botgros, Thomas L. Holland
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 63
Background The etiology of hospital-acquired or ventilator-associated bacterial pneumonia (HABP/VABP) is often multidrug-resistant infections. The evaluation of new antibacterial drugs for efficacy in this population is important, as many antibacteri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaada75ff77de527c4fd4ec5fa62e47f
https://pubmed.ncbi.nlm.nih.gov/27481950
https://pubmed.ncbi.nlm.nih.gov/27481950